Navigation Links
Advantage India: Growth Pills Abound For Pharma Companies

It's advantage Indian pharma companies and the needy patients who would have to fork out much less to purchase life-saving drugs, with global pharma giants like Merck and Pfizer losing// their patent on drugs commanding multi-billion annual sales.

Domestic pharma majors Ranbaxy and Dr Reddy's Laboratories are being touted as major beneficiaries to tap on a multi-billion dollar sales vacuum created by the patent expiry of two biggest blockbuster drugs in the US -- cholesterol- cutting drug Zocor and antidepressant Zoloft -- within the span of a week.

Merck's patent for Zocor that contributed USD 4.4 billion in the company's 2005 sales expired on June 23, while Pfizer loses its patent for Zoloft, which totalled USD 3.3 billion in 2005 sales, on June 30.

When a company loses its exclusive patent for a branded drug, market opens to a host of generic drugmakers that leads to a drop of nearly 80 per cent in the drug's price, which results in a major gain for consumers as well as the makers of generic version of these drugs.

While analysts expect good value addition in share prices of DRL and Ranbaxy on the back of patent related global news flow going forward, another pharma major Cipla has already outperformed the Sensex since June 14, when the 30-share barometer index had plummeted to its lowest level in past few months at 8,799.01.

Cipla has gained 17.91 per cent since June 14 as against a gain of 16.48 per cent in Sensex. Ranbaxy on the other hand rose 11.01 per cent and DRL 8.51 per cent during the same period.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Advantages of Red Wine
2. Inactivation of Rad9 in Tumor Cells Would Be Advantageous In Cancer Therapy
3. Competitive Advantage Are Attained In Which Freeloaders Are Punished
4. Retro Running Is Found To Be More Advantageous
5. New Antipsychotic Medications have Little Advantage Over Older Drugs
6. "New" Clear Advantages In Nuclear Medicine
7. HIV Takes Advantage of Rivalry among T cells
8. Advantage Coffee and Disadvantage-Diabetes
9. Obesity - An Advantage For MHD Patients
10. Advantage, Obese Men!!
11. Vitamin A supplementation inadequate in India: Need for effective strategies

Post Your Comments:
(Date:12/1/2009)...ncerous lesions, researchers say , , TUE...trasound, elastography helps distinguish between c...unnecessary biopsies, U.S. researchers have found....biopsied turn out to be benign, according to the A...m to improve specificity with ultrasound, and elas...
(Date:12/1/2009)...e/ -- For many employers, the issue of quality and...ployee benefit, it,s providing for the needs of th...is leading this effort, with the help of Concentra... at its corporate offices, bringing quality and co...s and their dependents. ,, Beginning in Janu...
(Date:12/1/2009)...rages People to ,Fight AIDS. Love Life., ,,... on World AIDS Day, Gay Men,s Health Crisis (GMHC)... diverse groups disproportionately affected by HIV...l methamphetamine use. GMHC is announcing an inno...ce, www.MyMethLife.org , which aims to curb the r...
(Date:12/1/2009)...hers using functional MRI , , TUESDAY,...lead can cause permanent brain damage, a new study...gion of the brain is spared from lead exposure. Di...," study author Kim Cecil, an imaging scientist at... a professor of radiology, pediatrics and neurosci...
(Date:12/1/2009)...lucose intolerance (a condition less severe than g...ar risk factors as early as three months after bir...ion in The Endocrine Society,s Journal of Clinica...rchers in this study sought to evaluate the relati... postpartum risk of metabolic syndrome (defined as...
Breaking Medicine News(10 mins):Health News:Ultrasound With Elastography May Cut Down on Biopsies 2Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 2Health News:Nation's Oldest AIDS Organization Launches Innovative Tool to Reach New Faces of HIV on World AIDS Day 3Health News:Childhood Lead Exposure Causes Permanent Damage: Study 2Health News:Glucose intolerance in pregnancy associated with postpartum cardiovascular risk 2
...ists Discuss the Latest Developments in Molecular,...l., Sept. 5 The practice of,pathology is at a tra...se,of personalized medicine will change the way pa...g a leadership role in,making sure that its member...
... Sept. 5 The Health Resources,and Services Admini...nts to,increase and improve medical services at th...e President Bush,s historic expansion of the,healt...izabeth M. Duke said. "In 2007, more than 16 milli...
...lain how theoretical ,anti-cloak, could bring obje...lthDay News) -- Just in case someone develops a cl...say they know how to uncloak the objects it hides....in. , Researchers at Shanghai Jiao Tong University...
...on John McCain to commit to develop a National AID..., Minn., Sep. 5 The,Republican National Conventio...stic AIDS epidemic in the United States and only p... in their remarks,to Convention delegates., The R...
...t. 5 Speaker Nancy Pelosi,issued the following st...,Up to Cancer" telethon, to be aired on all networ...y who has not seen a loved one,suffer because of c...icating the scourge of cancer a national priority ...
....Y., Sept. 5 Tonight is a momentous,occasion as t...industry,executives, celebrities and prominent lea...forces to Stand Up to Cancer. This collaboration,f...the discussion about cancer and the need to take a...
Other Medicine News:Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:The Leukemia & Lymphoma Society: Standing Up to Cancer for 60 Years 2
(Date:12/1/2009)...WATER, Fla., Dec. 1 CCS Medical, I...al supplies, today announced that it has received ...or District of Delaware (the "Court") for its bidd...d proposed sale of substantially all of its assets...09, the Court approved bidding procedures for the ...
(Date:12/1/2009)...A, Va., Dec. 1 CEL-SCI C...gy company and a developer of vaccines and therape...us diseases, announced today that it has retained ... Organization (CRO) to run CEL-SCI,s upcoming Phas...neck cancer with the Company,s lead product candid...
(Date:12/1/2009)...AUREL, N.J., Dec. 1 Me...f technology-enabled clinical documentation servic... from Primordial Design, Inc. has been integrated ...me speech recognition system. The solution is bein...h America (RSNA) convention November 29 through De...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Drinking Your Way to Health 3F Perhaps Not 59700 1Drinking Your Way to Health 3F Perhaps Not 59700 2Drinking Your Way to Health 3F Perhaps Not 59700 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 1UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 2UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 4UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 5UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 6UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 7UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 8UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 9UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 10UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 11UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 12Video Games Can Play Havoc With Kids Joints 59696 1Video Games Can Play Havoc With Kids Joints 59696 2Video Games Can Play Havoc With Kids Joints 59696 3
...NGTON, May 28 Robert Brackett, chief,science offi...), today,released the following statement in respo...rates reported in the latest issue of the Journal ...welcome the findings reported in today,s issue of ...AMA) indicating that the rise in,childhood and tee...
... SAN FRANCISCO, Calif., May 28 Sunesis,Pharmaceut...m ongoing,clinical trials of voreloxin (formerly S...., Updated interim data from Sunesis, ongoing Pha...tant ovarian cancer patients will be presented,dur... (ASCO) Annual Meeting,being held May 30 - June 3,...
Other Medicine Technology:Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 2Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress 3
Carpentier-Edwards PERIMOUNT Magna Aortic Heart Valve
Dimension Vista System
...background in high performance ultrasound design p...iography. Echocardiography imaging requires superi...tive Doppler performance. The Terason Echo Ultraso...ech Architecture, delivers a compact imaging platf...
...background in high performance portable ultrasound... echocardiography. Echocardiography (ultrasound) ... frame rates, and sensitive Doppler performance. ...ason's proprietary Teratech Architecture, delivers...
Medicine Products: